Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides
about
Gelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionNeutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor ProgressionRole of Nonmuscle Myosin II in Migration of Wharton's Jelly-Derived Mesenchymal Stem Cells.Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decadeTumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias.The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growthThe MMP-9/TIMP-1 axis controls the status of differentiation and function of myelin-forming Schwann cells in nerve regeneration.In vitro effects of a small-molecule antagonist of the Tcf/ß-catenin complex on endometrial and endometriotic cells of patients with endometriosis.MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell lineProteolysis during tumor cell extravasation in vitro: metalloproteinase involvement across tumor cell types.Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9Matrix metalloproteinase-9 expression is enhanced in renal parietal epithelial cells of zucker diabetic Fatty rats and is induced by albumin in in vitro primary parietal cell cultureInhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.Recruitment of Matrix Metalloproteinase-9 (MMP-9) to the Fibroblast Cell Surface by Lysyl Hydroxylase 3 (LH3) Triggers Transforming Growth Factor-β (TGF-β) Activation and Fibroblast DifferentiationTargeting the Wnt/β-catenin pathway in endometriosis: a potentially effective approach for treatment and prevention.Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old IdeasMatrix metalloproteinases as breast cancer drivers and therapeutic targets.A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells.A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosisA Disintegrin and Metalloproteinase with Thrombospondin Motifs-5 (ADAMTS-5) Forms Catalytically Active OligomersMultiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic diseasePeptide-based selective inhibitors of matrix metalloproteinase-mediated activitiesA single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy.CD44 targets Na(+)/H(+) exchanger 1 to mediate MDA-MB-231 cells' metastasis via the regulation of ERK1/2.Matrix metalloproteinase-2 as a target for head and neck cancer therapy.Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2).Cell-Surface MMP-9 Protein Is a Novel Functional Marker to Identify and Separate Proangiogenic Cells from Early Endothelial Progenitor Cells Derived from CD133(+) Cells.Failure of matrix metalloproteinase-9 dimer induction by phorbol 12-myristate 13-acetate in normal human cell lines.CO-releasing molecules CORM2 attenuates angiotensin II-induced human aortic smooth muscle cell migration through inhibition of ROS/IL-6 generation and matrix metalloproteinases-9 expression.The Cell Surface Receptor CD44: NMR-Based Characterization of Putative Ligands.Establishment of oral squamous cell carcinoma cell line and magnetic bead-based isolation and characterization of its CD90/CD44 subpopulations.Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.Angiogenic Role of MMP-2/9 Expressed on the Cell Surface of Early Endothelial Progenitor Cells/Myeloid Angiogenic Cells.Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.
P2860
Q24568374-E3EE06FB-1FBB-4D15-B2F8-5AFC5CBF5EA8Q26765238-F16279AD-F271-4C02-86C2-F6F08C6D1ADBQ27307088-7F1B27B0-9C42-489D-B95C-4D596EDA5F0EQ28288148-3F59520F-E6A0-4A6A-9BD0-5DE394C7C54FQ33757096-139FF1D6-4BE3-4DA2-B373-27F5C5FC6745Q33820258-49FD655E-CC6A-4E56-8067-2BC3F30BFECCQ33958763-EF7707C5-FBD8-406A-A311-2146F900A49EQ34075901-2A745026-0A97-4569-9285-4834B2488CC8Q34190659-ADC6D524-715E-4F99-A952-8E2D566A214EQ34206417-5510AFAB-184F-46C8-A168-7786C1543AA3Q34692280-88CAAFED-F223-4E11-A67B-0B8A6CAD9E41Q34902779-6E2CB6BB-F216-4FAE-9C8B-50611B07AE79Q35032566-CB4B4D7C-B0D0-4326-AF46-41DFB2DA1CBCQ35112695-706696A4-8FC0-4343-AE7B-4316E153A25BQ35303995-B16C6FF3-CF1E-4E5F-B7C0-A60900F2579EQ35313033-083CD9C4-2219-4B91-AFA7-05926BA96C29Q35447969-CB3AB29C-2091-4139-938E-901826AFCB1CQ35662257-17080911-3E2C-40BD-8718-547EFC61441BQ35673625-014BF1D6-7A15-41EC-AED2-FC7C09D7CFB5Q35760031-01CB40E3-961B-4943-9E7B-303F9F7426BBQ35892721-92FD872B-8C83-4570-8835-495C9EC138FDQ36201708-73D01AE7-BD44-45CE-8133-EEF3340C6AFDQ36348395-AB6A87F3-7661-4077-BE27-069BFAC8A8EAQ36521006-1BE69E01-EE19-438A-AC35-A9C3DB71318BQ36573930-0547C788-2334-48D2-A2B9-797AC6D4E783Q36867284-EB93F79D-A8D4-42C3-8438-1CFD23B43A84Q36919032-7DC3EBEC-2982-4943-85EF-0A6002C00983Q36924491-19F47EFF-9C3F-4C8C-97E7-CA23FB46010BQ37594390-CA612A9B-F8B3-49BC-99E7-89E332BF8EB8Q38068476-546727CF-8E9E-467F-9C89-FB7105F389F9Q38725320-00C4B870-8F79-4489-A5C4-B963B7592A52Q39197180-6AE95D07-554B-4381-88B8-C625B7303C5EQ40043634-177720D0-6996-47A6-8CC3-34C56C3F277AQ40773929-00C13727-C0C1-43BD-AE83-57444CD924EEQ42316580-3BDCB962-D688-4392-83C3-DBB42EAD16FEQ42327548-BDCAB53D-2F8E-46C3-B9EC-8DBD37F62D8EQ42371627-57EC5708-4431-490E-902C-DA5D0E86889EQ42720277-600E8A80-6618-4691-B239-47B2667F0A96Q45874371-A9E04193-8704-40EF-A83F-D87AAD4ECF29Q47748198-A1B00784-A0F4-4ABA-9569-DB8F0A35630D
P2860
Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of matrix metalloproteina ...... design of inhibitory peptides
@ast
Role of matrix metalloproteina ...... design of inhibitory peptides
@en
Role of matrix metalloproteina ...... design of inhibitory peptides
@nl
type
label
Role of matrix metalloproteina ...... design of inhibitory peptides
@ast
Role of matrix metalloproteina ...... design of inhibitory peptides
@en
Role of matrix metalloproteina ...... design of inhibitory peptides
@nl
prefLabel
Role of matrix metalloproteina ...... design of inhibitory peptides
@ast
Role of matrix metalloproteina ...... design of inhibitory peptides
@en
Role of matrix metalloproteina ...... design of inhibitory peptides
@nl
P2093
P2860
P356
P1476
Role of matrix metalloproteina ...... design of inhibitory peptides
@en
P2093
Antoine Dufour
Nicole S Sampson
Stanley Zucker
P2860
P304
35944-35956
P356
10.1074/JBC.M109.091769
P407
P50
P577
2010-09-13T00:00:00Z